Detalles de la búsqueda
1.
Concordance between results of inexpensive statistical models and multigene signatures in patients with ER+/HER2- early breast cancer.
Mod Pathol
; 34(7): 1297-1309, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33558657
2.
Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor-Positive, HER-2 Negative Breast Cancer.
Oncologist
; 24(2): 165-171, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30171067
3.
Identification, clinical-pathological characteristics and treatment outcomes of patients with metastatic breast cancer and somatic human epidermal growth factor receptor 2 (ERBB2) mutations.
Breast Cancer Res Treat
; 174(1): 55-63, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30456437
4.
Tumor characteristics and outcome by androgen receptor expression in triple-negative breast cancer patients treated with neo-adjuvant chemotherapy.
Breast Cancer Res Treat
; 176(3): 699-708, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31106385
5.
Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium.
Int J Cancer
; 141(9): 1830-1840, 2017 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28670784
6.
The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients.
Br J Cancer
; 115(12): 1471-1478, 2016 Dec 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27802449
7.
Androgen deprivation by adrenal suppression using low-dose hydrocortisone for the treatment of breast carcinoma with apocrine features: a case report illustrating this new paradigm.
Breast Cancer Res Treat
; 155(3): 603-7, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26868122
8.
The UZ Leuven Policy for Extended Adjuvant Anti-estrogen Therapy in Women With Early Estrogen Receptor-Positive Breast Cancer.
Curr Treat Options Oncol
; 16(7): 31, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26031545
9.
Body Mass Index and Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.
J Natl Cancer Inst
; 113(2): 146-153, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33152071
10.
Correction to: Unexpected Benefit from Alpelisib and Fulvestrant in a Woman with Highly Pre-treated ER-Positive, HER2-Negative PIK3CA Mutant Metastatic Breast Cancer.
Clin Drug Investig
; 39(1): 113, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30637612
11.
Tamoxifen Pharmacogenetics and Metabolism: Results From the Prospective CYPTAM Study.
J Clin Oncol
; 37(8): 636-646, 2019 03 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30676859
12.
Decentralization of Next-Generation RNA Sequencing-Based MammaPrint® and BluePrint® Kit at University Hospitals Leuven and Curie Institute Paris.
Transl Oncol
; 12(12): 1557-1565, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31513983
13.
Unexpected Benefit from Alpelisib and Fulvestrant in a Woman with Highly Pre-treated ER-Positive, HER2-Negative PIK3CA Mutant Metastatic Breast Cancer.
Clin Drug Investig
; 38(11): 1071-1075, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30187361
14.
Tamoxifen Metabolism and Efficacy in Breast Cancer: A Prospective Multicenter Trial.
Clin Cancer Res
; 24(10): 2312-2318, 2018 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29459457
Resultados
1 -
14
de 14
1
Próxima >
>>